It’s not impossible to get infected with SARS-CoV-2 from contaminated surfaces—but the risk is extremely low—less than 1 in 10,000, the CDC confirmed yesterday,
March 19, 2021
Overlooked during the global fixation on vaccinations: oral antivirals pills. A pill-based “Tamiflu approach” would be easier than current therapies like monoclonal antibodies and convalescent plasma that need intravenous infusions.
February 25, 2021
Good news on reinfection front: US NIH researchers found that people with SARS-CoV-2 antibodies showed “substantial” immunity to the virus at least for a few months,
January 4, 2021
A new South Africa variant of SARS-CoV-2 is prompting concerns about increased transmission and how effective current vaccines will be against it,
December 21, 2020
The SARS-CoV-2 mutation now rapidly spreading across England’s South East is potentially up to 70% more infectious than its predecessor—but not necessarily more dangerous, according to a new
December 15, 2020
Could a novel strain of SARS-CoV-2 identified this month be linked to an accelerating spread in the country’s southeast?
December 7, 2020
WHO advisors are meeting today to discuss deliberately infecting young, healthy volunteers with SARS-CoV-2 to hasten vaccine development—despite the promising vaccines already on the way. Pros: Faster results than conventional vaccine field trials…
December 2, 2020
117 pages of leaked documents reveal that early in the pandemic, China offered the world a partial picture of what they knew and a more optimistic forecast than what was evidenced on the ground. Despite the virus’s novelty, there was “evidence of clear missteps” and “a…
November 18, 2020
Less disruptive and costly COVID-19 restrictions can work as well as more intrusive steps like lockdowns to slow the spread of SARS-CoV2, according to a new study ranking the effectiveness of government interventions around the world. The researchers from the Medical…
November 16, 2020
More good vaccine news broke this morning as biotech company Moderna announced